2022-08-12 |
2022-08-11 |
A
Achat
|
Rubric Capital Management LP
Actionnaire important
|
1 678 954
+24.1%
10,07
16 907 067 USD
|
1 678 954
+24.1%
|
10,07
|
16 907 067 USD
|
|
2022-08-11 |
2022-08-10 |
A
Achat
|
Rubric Capital Management LP
Actionnaire important
|
4 012
+0.1%
10,07
40 401 USD
|
4 012
+0.1%
|
10,07
|
40 401 USD
|
|
2022-05-20 |
2022-05-18 |
A
Achat
|
BIOTECH TARGET N V
Actionnaire important
|
477 824
+5.8%
5,57
2 661 002 USD
|
477 824
+5.8%
|
5,57
|
2 661 002 USD
|
|
2022-01-07 |
2022-01-06 |
A
Achat
|
BIOTECH TARGET N V
Actionnaire important
|
300 000
+3.8%
6,31
1 894 410 USD
|
300 000
+3.8%
|
6,31
|
1 894 410 USD
|
|
2022-01-07 |
2022-01-05 |
A
Achat
|
BIOTECH TARGET N V
Actionnaire important
|
250 000
+3.2%
6,30
1 574 650 USD
|
250 000
+3.2%
|
6,30
|
1 574 650 USD
|
|
2021-12-16 |
2021-12-16 |
A
Achat
|
Rubric Capital Management LP
Actionnaire important
|
146 685
+2.2%
7,07
1 037 752 USD
|
146 685
+2.2%
|
7,07
|
1 037 752 USD
|
|
2021-12-15 |
2021-12-15 |
A
Achat
|
Rubric Capital Management LP
Actionnaire important
|
180 744
+2.7%
6,77
1 223 637 USD
|
180 744
+2.7%
|
6,77
|
1 223 637 USD
|
|
2021-12-15 |
2021-12-14 |
A
Achat
|
Rubric Capital Management LP
Actionnaire important
|
94 103
+1.4%
6,81
640 936 USD
|
94 103
+1.4%
|
6,81
|
640 936 USD
|
|
2021-12-15 |
2021-12-13 |
A
Achat
|
Rubric Capital Management LP
Actionnaire important
|
187 391
+3.0%
7,08
1 326 803 USD
|
187 391
+3.0%
|
7,08
|
1 326 803 USD
|
|
2021-12-10 |
2021-12-10 |
A
Achat
|
Rubric Capital Management LP
Actionnaire important
|
768 171
+13.8%
7,18
5 511 627 USD
|
768 171
+13.8%
|
7,18
|
5 511 627 USD
|
|
2021-12-10 |
2021-12-09 |
A
Achat
|
Rubric Capital Management LP
Actionnaire important
|
264 644
+5.0%
7,58
2 007 087 USD
|
264 644
+5.0%
|
7,58
|
2 007 087 USD
|
|
2021-12-10 |
2021-12-08 |
A
Achat
|
Rubric Capital Management LP
Actionnaire important
|
560 691
+11.8%
8,02
4 497 078 USD
|
560 691
+11.8%
|
8,02
|
4 497 078 USD
|
|
2021-10-01 |
2021-09-29 |
A
Achat
|
BIOTECH TARGET N V
Actionnaire important
|
100 000
+1.3%
12,95
1 294 500 USD
|
100 000
+1.3%
|
12,95
|
1 294 500 USD
|
|
2021-03-09 |
2021-03-05 |
VP
Vente planifiée
|
Chopas James George
Principal Finance Accounting
Dirigeant
|
370
-5.2%
20,88
7 726 USD
|
370
-5.2%
|
20,88
|
7 726 USD
|
|
2021-02-26 |
2021-02-25 |
V
Vente
|
Grausso Sal
Chief Commercial Officer
Dirigeant
|
1 322
-10.1%
18,93
25 025 USD
|
1 322
-10.1%
|
18,93
|
25 025 USD
|
|
2020-11-09 |
2020-11-05 |
A
Achat
|
BIOTECH TARGET N V
Actionnaire important
|
100 000
+1.4%
14,26
1 426 230 USD
|
100 000
+1.4%
|
14,26
|
1 426 230 USD
|
|
2020-09-16 |
2020-09-14 |
A
Achat
|
BIOTECH TARGET N V
Actionnaire important
|
200 000
+2.8%
11,69
2 338 680 USD
|
200 000
+2.8%
|
11,69
|
2 338 680 USD
|
|
2020-09-14 |
2020-09-11 |
A
Achat
|
BIOTECH TARGET N V
Actionnaire important
|
199 029
+2.9%
11,33
2 255 118 USD
|
199 029
+2.9%
|
11,33
|
2 255 118 USD
|
|
2020-07-09 |
2020-07-08 |
A
Achat
|
BIOTECH TARGET N V
Actionnaire important
|
25 000
+0.4%
13,21
330 178 USD
|
25 000
+0.4%
|
13,21
|
330 178 USD
|
|
2020-05-04 |
2020-04-30 |
A
Achat
|
BIOTECH TARGET N V
Actionnaire important
|
50 000
+0.7%
15,75
787 555 USD
|
50 000
+0.7%
|
15,75
|
787 555 USD
|
|
2020-02-28 |
2020-02-26 |
VP
Vente planifiée
|
Hughes Owen
Administrateur non-exécutif
|
2 750
-20.5%
17,95
49 363 USD
|
2 750
-20.5%
|
17,95
|
49 363 USD
|
|
2020-02-28 |
2020-02-26 |
V
Vente
|
Carmona Jose
Chief Financial Officer
Dirigeant
|
1 292
-2.7%
17,93
23 169 USD
|
1 292
-2.7%
|
17,93
|
23 169 USD
|
|
2020-02-28 |
2020-02-26 |
VP
Vente planifiée
|
Dere Willard H
Administrateur non-exécutif
|
1 925
-13.6%
17,95
34 554 USD
|
1 925
-13.6%
|
17,95
|
34 554 USD
|
|
2020-02-28 |
2020-02-26 |
V
Vente
|
Morris Charles Q
Chief Medical Officer
Dirigeant
|
1 256
-3.6%
17,93
22 524 USD
|
1 256
-3.6%
|
17,93
|
22 524 USD
|
|
2020-02-28 |
2020-02-26 |
VP
Vente planifiée
|
Rosenberg Anthony
Administrateur non-exécutif
|
1 815
-12.8%
17,95
32 579 USD
|
1 815
-12.8%
|
17,95
|
32 579 USD
|
|
2020-02-28 |
2020-02-26 |
V
Vente
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
Dirigeant
|
889
-3.6%
17,93
15 942 USD
|
889
-3.6%
|
17,93
|
15 942 USD
|
|
2019-11-08 |
2019-11-06 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
100 000
+1.5%
23,00
2 300 300 USD
|
100 000
+1.5%
|
23,00
|
2 300 300 USD
|
|
2019-07-03 |
2019-07-01 |
VP
Vente planifiée
|
Rosenberg Anthony
|
1 584
-15.4%
24,60
38 966 USD
|
1 584
-15.4%
|
24,60
|
38 966 USD
|
|
2019-06-11 |
2019-06-07 |
A
Achat
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
|
2 500
+50.0%
21,81
54 536 USD
|
2 500
+50.0%
|
21,81
|
54 536 USD
|
|
2019-05-13 |
2019-05-10 |
A
Achat
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
|
2 000
+66.7%
21,43
42 860 USD
|
2 000
+66.7%
|
21,43
|
42 860 USD
|
|
2019-04-18 |
2019-04-16 |
VP
Vente planifiée
|
Dere Willard H
|
1 680
-16.3%
22,22
37 330 USD
|
1 680
-16.3%
|
22,22
|
37 330 USD
|
|
2019-04-18 |
2019-04-16 |
VP
Vente planifiée
|
Graves Kurt
|
4 800
-46.6%
22,32
107 136 USD
|
4 800
-46.6%
|
22,32
|
107 136 USD
|
|
2019-04-18 |
2019-04-16 |
VP
Vente planifiée
|
Hughes Owen
|
2 400
-23.3%
22,22
53 328 USD
|
2 400
-23.3%
|
22,22
|
53 328 USD
|
|
2019-04-12 |
2019-04-11 |
VP
Vente planifiée
|
Roychowdhury Debasish
|
4 800
-46.6%
22,15
106 320 USD
|
4 800
-46.6%
|
22,15
|
106 320 USD
|
|
2019-03-06 |
2019-03-05 |
A
Achat
|
Hopfield Jessica
|
12 800
+inf%
19,23
246 190 USD
|
12 800
+inf%
|
19,23
|
246 190 USD
|
|
2018-12-21 |
2018-12-20 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
60 000
+0.9%
14,48
868 782 USD
|
60 000
+0.9%
|
14,48
|
868 782 USD
|
|
2018-12-18 |
2018-12-17 |
A
Achat
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
Dirigeant
|
3 000
+inf%
15,71
47 130 USD
|
3 000
+inf%
|
15,71
|
47 130 USD
|
|
2018-12-17 |
2018-12-14 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
60 000
+0.9%
15,64
938 256 USD
|
60 000
+0.9%
|
15,64
|
938 256 USD
|
|
2018-08-22 |
2018-08-20 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
60 000
+0.9%
19,65
1 178 808 USD
|
60 000
+0.9%
|
19,65
|
1 178 808 USD
|
|
2018-08-16 |
2018-08-15 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
69 363
+1.1%
20,78
1 441 530 USD
|
69 363
+1.1%
|
20,78
|
1 441 530 USD
|
|
2018-08-16 |
2018-08-14 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
100 000
+1.6%
20,87
2 086 880 USD
|
100 000
+1.6%
|
20,87
|
2 086 880 USD
|
|
2018-08-10 |
2018-08-08 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
60 000
+1.0%
22,73
1 363 884 USD
|
60 000
+1.0%
|
22,73
|
1 363 884 USD
|
|
2018-07-30 |
2018-07-27 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.8%
24,81
1 240 605 USD
|
50 000
+0.8%
|
24,81
|
1 240 605 USD
|
|
2018-07-26 |
2018-07-25 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.8%
27,28
1 363 805 USD
|
50 000
+0.8%
|
27,28
|
1 363 805 USD
|
|
2018-06-13 |
2018-06-11 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.8%
27,36
1 367 835 USD
|
50 000
+0.8%
|
27,36
|
1 367 835 USD
|
|
2018-05-24 |
2018-05-23 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
40 000
+0.7%
28,91
1 156 320 USD
|
40 000
+0.7%
|
28,91
|
1 156 320 USD
|
|
2018-05-23 |
2018-05-21 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
60 000
+1.0%
29,27
1 756 380 USD
|
60 000
+1.0%
|
29,27
|
1 756 380 USD
|
|
2018-04-23 |
2018-04-19 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
40 000
+0.7%
33,80
1 351 936 USD
|
40 000
+0.7%
|
33,80
|
1 351 936 USD
|
|
2018-04-09 |
2018-04-05 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.9%
36,58
1 828 845 USD
|
50 000
+0.9%
|
36,58
|
1 828 845 USD
|
|
2018-03-06 |
2018-03-02 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
80 000
+1.4%
32,52
2 601 448 USD
|
80 000
+1.4%
|
32,52
|
2 601 448 USD
|
|
2018-02-12 |
2018-02-09 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
75 000
+1.3%
34,38
2 578 763 USD
|
75 000
+1.3%
|
34,38
|
2 578 763 USD
|
|
2017-11-16 |
2017-11-14 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.9%
26,25
1 312 390 USD
|
50 000
+0.9%
|
26,25
|
1 312 390 USD
|
|
2017-11-13 |
2017-11-10 |
A
Achat
|
Hatzis-Schoch Brent
Sr. VP, General Counsel
|
1 778
+355.6%
28,09
49 943 USD
|
1 778
+355.6%
|
28,09
|
49 943 USD
|
|
2017-11-07 |
2017-11-07 |
A
Achat
|
Hoiland Jesper
President and CEO
Administrateur exécutif
|
6 800
+111.5%
29,04
197 450 USD
|
6 800
+111.5%
|
29,04
|
197 450 USD
|
|
2017-11-07 |
2017-11-03 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.9%
29,15
1 457 575 USD
|
50 000
+0.9%
|
29,15
|
1 457 575 USD
|
|
2017-10-27 |
2017-10-26 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.9%
30,95
1 547 550 USD
|
50 000
+0.9%
|
30,95
|
1 547 550 USD
|
|
2017-10-26 |
2017-10-25 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.9%
32,85
1 642 415 USD
|
50 000
+0.9%
|
32,85
|
1 642 415 USD
|
|
2017-09-15 |
2017-09-15 |
A
Achat
|
Hoiland Jesper
President and CEO
Administrateur exécutif
|
6 100
+inf%
32,72
199 608 USD
|
6 100
+inf%
|
32,72
|
199 608 USD
|
|
2017-09-15 |
2017-09-14 |
A
Achat
|
Carmona Jose
Chief Financial Officer
|
3 000
+inf%
32,83
98 503 USD
|
3 000
+inf%
|
32,83
|
98 503 USD
|
|
2017-09-15 |
2017-09-14 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.9%
32,94
1 647 225 USD
|
50 000
+0.9%
|
32,94
|
1 647 225 USD
|
|
2017-09-15 |
2017-09-13 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
100 000
+1.9%
33,71
3 370 750 USD
|
100 000
+1.9%
|
33,71
|
3 370 750 USD
|
|
2017-09-13 |
2017-09-12 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+0.9%
35,42
1 770 820 USD
|
50 000
+0.9%
|
35,42
|
1 770 820 USD
|
|
2017-09-07 |
2017-09-05 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+1.0%
36,75
1 837 625 USD
|
50 000
+1.0%
|
36,75
|
1 837 625 USD
|
|
2017-08-18 |
2017-08-16 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
60 000
+1.2%
35,98
2 158 536 USD
|
60 000
+1.2%
|
35,98
|
2 158 536 USD
|
|
2017-08-11 |
2017-08-10 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
75 000
+1.5%
34,26
2 569 500 USD
|
75 000
+1.5%
|
34,26
|
2 569 500 USD
|
|
2017-08-11 |
2017-08-09 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
75 000
+1.5%
35,67
2 675 528 USD
|
75 000
+1.5%
|
35,67
|
2 675 528 USD
|
|
2017-05-31 |
2017-05-30 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
40 000
+0.8%
34,21
1 368 348 USD
|
40 000
+0.8%
|
34,21
|
1 368 348 USD
|
|
2017-05-30 |
2017-05-25 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
40 000
+0.8%
36,25
1 450 020 USD
|
40 000
+0.8%
|
36,25
|
1 450 020 USD
|
|
2017-05-22 |
2017-05-18 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+1.0%
34,41
1 720 345 USD
|
50 000
+1.0%
|
34,41
|
1 720 345 USD
|
|
2017-05-18 |
2017-05-17 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
18 000
+0.4%
32,98
593 662 USD
|
18 000
+0.4%
|
32,98
|
593 662 USD
|
|
2017-05-18 |
2017-05-16 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
17 000
+0.3%
33,93
576 725 USD
|
17 000
+0.3%
|
33,93
|
576 725 USD
|
|
2017-05-16 |
2017-05-12 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
15 000
+0.3%
34,00
509 996 USD
|
15 000
+0.3%
|
34,00
|
509 996 USD
|
|
2017-05-11 |
2017-05-09 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
50 000
+1.0%
35,93
1 796 480 USD
|
50 000
+1.0%
|
35,93
|
1 796 480 USD
|
|
2017-05-09 |
2017-05-08 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
22 800
+0.5%
35,60
811 630 USD
|
22 800
+0.5%
|
35,60
|
811 630 USD
|
|
2017-05-09 |
2017-05-05 |
A
Achat
|
BIOTECH GROWTH N V
Actionnaire important
|
20 600
+0.4%
35,55
732 283 USD
|
20 600
+0.4%
|
35,55
|
732 283 USD
|
|